Format

Send to

Choose Destination
Lancet Oncol. 2019 Jun;20(6):e292. doi: 10.1016/S1470-2045(19)30342-0.

Key considerations when reviewing subsequent primary cancers following radiotherapy - Authors' reply.

Author information

1
National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
2
Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
3
National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan. Electronic address: makishima.hirokazu@qst.go.jp.
4
Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan; Graduate School of Medicine, Osaka University, Osaka, Japan.
5
National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263-8555, Japan.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center